CN1370569A - Composite Chinese medicine powder for treating burns and scalds - Google Patents
Composite Chinese medicine powder for treating burns and scalds Download PDFInfo
- Publication number
- CN1370569A CN1370569A CN01107834A CN01107834A CN1370569A CN 1370569 A CN1370569 A CN 1370569A CN 01107834 A CN01107834 A CN 01107834A CN 01107834 A CN01107834 A CN 01107834A CN 1370569 A CN1370569 A CN 1370569A
- Authority
- CN
- China
- Prior art keywords
- powder
- weight portions
- chinese medicine
- weight
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The composite Chinese medicine powder for treating burns and scalds is compounded with Astragalus membranaceus powder, cimicifuga powder, Rhizoma bletillae powder, rhubarb powder, pricklyash powder, etc. Clinical application shows that the composite Chinese medicine powder has high treating effect and no infection.
Description
The invention provides a kind of Chinese medicine composition, particularly a kind of Chinese medicine composition composition powders for the treatment of burn and scald.
The burn and scald disease is a kind of disease comparatively thorny in the clinical surgery, and the burn and scald accident constantly takes place in daily life.The existing burn class medicine curative effect of scalding is not too satisfactory, and is more with rehabilitation stage complication during the treatment, is difficult to expect and control.As being prone to shock, infection etc. during the treatment of the boiling hot burn wound of moderate, even multiple organs failure appears, many after the rehabilitation with scar hyperplasia, thermoregulation dysfunction, wound surface pruritus pain, scar ulcer etc., the dark above wound surface healing time of II degree is long, expense is high, so-called " residual wound " appears in Chang Fanfu, need repeatedly carry out skin grafting and could cure.
The purpose of this invention is to provide a kind of Chinese medicine composition composition powders for the treatment of burn and scald, to improve the therapeutic effect of burn and scald.
The present invention is achieved in that a kind of Chinese medicine composition composition powders for the treatment of burn and scald, and its proportioning is:
Astragalus membranaceus powder 3~15 weight portions
Rhizoma Cimicifugae powder 3~15 weight portions
Pseudobulbus Bletillae (Rhizoma Bletillae) powder 3~7 weight portions
Radix Et Rhizoma Rhei powder 3~15 weight portions
Hot pepper powder 3~9 weight portions
Corium elephatis powder 0.5~2 weight portion
Margarita powder 1~5 weight portion
Mentholum 1~5 weight portion
Moschus 0.08~0.15 weight portion
Indigo Naturalis 1~5 weight portion
A kind of best proportioning for the treatment of the Chinese medicine composition of burn and scald of the present invention is:
Astragalus membranaceus powder 9 weight portions
Rhizoma Cimicifugae powder 9 weight portions
Pseudobulbus Bletillae (Rhizoma Bletillae) powder 5 weight portions
Radix Et Rhizoma Rhei powder 9 weight portions
Hot pepper powder 5 weight portions
Corium elephatis powder 1 weight portion
Margarita powder 3 weight portions
Mentholum 3 weight portions
Moschus 0.1 weight portion
Indigo Naturalis 3 weight portions
Described astragalus membranaceus powder, Rhizoma Cimicifugae powder, Pseudobulbus Bletillae (Rhizoma Bletillae) powder, Radix Et Rhizoma Rhei powder are to be smalls by the Radix Astragali, Rhizoma Cimicifugae, the Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Et Rhizoma Rhei pulverizing respectively, obtain behind 120 mesh sieves excessively; Hot pepper powder is for to smash Fructus Zanthoxyli medication ware, removes it and is difficult for the wooden part pulverized, pulverizes to be smalls again, crosses to obtain behind 120 mesh sieves; The Corium elephatis powder is that Corium elephatis is fried back pulverization, obtains behind 120 mesh sieves excessively; Margarita powder is that water flies to obtain behind the pulverization, and its fineness degree also was 120 mesh sieves.The Corium elephatis powder, adds and makes this powder after other medicines grind well after Moschus grinds well with Mentholum, Margarita powder.After the interior sealing of the vial of can packing into, put into refrigerator and take out after freezing 24 hours, or be placed in the refrigerator standby.
The present invention is monarch with the Radix Astragali, and Rhizoma Cimicifugae, Moschus are minister, can play intestinal stasis relieving blood stasis dispelling effect; The Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Et Rhizoma Rhei, Margarita, Mentholum, Indigo Naturalis, Corium elephatis are assistant; Can play granulation promoting and hold back skin; Fructus Zanthoxyli is for making.The Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Et Rhizoma Rhei all have the report that is used for the treatment of the burn and scald aspect in a large number.Indigo Naturalis, Radix Et Rhizoma Rhei and Mentholum totally 5, the effect of sterilization is better.Margarita has good promoting muscle growth functions.
The present invention's powder be used for clinical after, result of use shows and has the following advantages:
1, good effect: shallow II degree burn and scald is general only to need dispenser once, but can form one deck incrustation in three hours. non-pigment calmness after the recovery from illness of new wound face.After dark II degree, III degree were hindered the face dispenser, unstripped slough can break away from fast voluntarily, and is filled by granulation tissue soon.
2, there is not infection: do not have the infection problem generally speaking and occur.
3, shock: since solved body fluid lose and infect two large problems again, therefore alleviate or avoided the generation of suffering a shock.
4, recovery from illness is fast: more existing other drug treatment required time is short.As the shallow II degree that accounts for human body 1/3 hinders face, generally beginning decrustation on the five, purifies fully in 15 days.
5, more the back is good: shallow II degree can not have cicatrix, no pruritus after hindering the face recovery from illness, and no blister is regenerated, the basic non-pigment calmness of skin, hair and normally being as good as substantially.After dark II degree and III degree were healed, scar hyperplasia was low than other medicine terateger rate.
6, expense is low: low than the required expense of other medicine.
Further specify the present invention below.
During use, earlier the patient is hindered face and clean up, soak repeated affected part with ice or frozen water external application.Its principle is that extremity behind, waist buttocks should be used the direct external application of ice; Pile should or be soaked with the frozen water external application in abdominal part, front, and pile should soak with frozen water repeatedly in joint, eye, nose, larynx, big positive cave, Fengchi acupoint, halogen door, SHENQUE acupoint and cloudy place etc.General persistence is about 1~3 hour.The length of time generally is that the male is long than women's time, young old, the weakling's length of between twenty and fifty, body powerhouse, fat person is long than the thin person of body, and extremity, waist, the back of the body, buttocks be head, face, breast, abdomen, joint length, area is little to be greatly enhanced than area, and the condition of the injury is shallow more profound than the condition of the injury.
After above cold compress, remove the appearance slough.
After removing totally, at the powder of hindering face external application thin layer (generally below 1 millimeters thick) the present invention.
It is dark or when the slough that should not remove is in a large number arranged to hinder face, after the medication, can wipe molten soft medicine film or/and continue dispenser (this powder has the effect of solution-off slough) behind the slough that breaks away from, once a day till incrustation fully.
During the large tracts of land burn and scald, can cooperate antiinflammatory transfusion etc.
The treatment mechanism of the present invention's powder is: the present invention's powder external application is hindered face transudate and part residual tissue and is formed one deck incrustation rapidly, thereby stoped the consumption of hindering face body fluid after hindering face, hinders face and has recovered external environment condition and significantly reduced infection chance.Under this good condition, the damaged face forms one deck " tunica albuginea " fast, and the incrustation on surface is also just firm thereupon.Like this, through after a while, hinder the very fast recovery of skin histology, the recovery from illness of face damage, incrustation also just comes off naturally.Darker hinder face and after the several drug of topical application, also can fully recover.
It below is the clinical test results of the present invention's powder.
Test group: use this powder to treat by above-mentioned using method.Case load has 100 examples.Wherein male 41 examples, women 59 examples.Minimum 1.5 years old of age, maximum 73 years old.Matched group:, treat by its conventional using method with treatment burn and scald " JINGWANHONG " commonly used.Case load has 73 examples, wherein male 34 examples, women 39 examples, minimum 1.2 years old of age, maximum 66 years old.
" surgery " that the burn degree can be published by People's Health Publisher April in 1994 the 3rd edition, the chapter 11 first segment, the heat injury record, " burn seriousness calibration " is as following table:
The degree of depth | Slightly | Moderate | Severe | Extra heavy | |
The adult | The II degree | ??≤9% | ???10~29% | ???30~49% | ??>50% |
The III degree | ???<10% | ???10~19% | ??>20% | ||
Children's | The II degree | ??≤5% | ???6~15% | ???16~25% | ??>25% |
The III degree | ????<5% | ????6~10% | ??>10% |
Also can carry out calibration by the present world habitual " three degree quarterings ".
The criterion of curative effect:
Excellent: as to be as good as substantially with normal skin, the no XOR of tissue.
Very: few cicatrix does not influence function, no residual wound substantially.
Can: cicatrix is arranged, influence function, residual wound is arranged.
Bad: disunion or death.
Press the curative effect such as the following table (each percent accounts for the corresponding percent of respectively organizing the case sum for it in the table, down together) of " burn seriousness calibration " the present invention's powder (test group):
Curative effect such as following table by " burn seriousness calibration " JINGWANHONG (matched group):
Press the curative effect such as the following table of " three degree quarterings " the present invention's powder (test group):
Curative effect such as following table by " three degree quarterings " JINGWANHONG (matched group):
Case load | Excellent (%) | Very (%) | Can (%) | Bad (%) | |
Slightly | ????38 | ????33 | ????5 | ||
Moderate | ????42 | ????8 | ????15 | ????18 | ????1 |
Severe | ????11 | ????2 | ????1 | ????3 | ????5 |
Extra heavy | ????9 | ????2 | ????2 | ????5 |
Case load | Excellent (%) | Very (%) | Can (%) | Bad (%) | |
Slightly | ???34 | ????15.1 | ????17.8 | ????9.6 | ????4.1 |
Moderate | ???26 | ????1.4 | ????6.8 | ????12.3 | ????15.1 |
Severe | ???10 | ????1.4 | ????12.3 | ||
Extra heavy | ????3 | ????4.1 |
Case load | Excellent (%) | Very (%) | Can (%) | Bad (%) | |
Shallow II degree | ???56 | ???53 | ????3 | ||
Dark II degree | ???41 | ????7 | ????31 | ????3 | |
The III degree | ????3 | ????2 | ????1 |
Case load | Excellent (%) | Very (%) | Can (%) | Bad (%) | |
Shallow II degree | ???53 | ????9.6 | ???20.5 | ???24.6 | ???17.8 |
Dark II degree | ???19 | ????1.4 | ????6.8 | ???17.8 | |
The III degree | ???1 | ????1.4 |
As can be seen from the above table, the therapeutic effect of the present invention's powder is better than the therapeutic effect of " JINGWANHONG " commonly used at present.
Claims (2)
1, a kind of Chinese medicine composition composition powders for the treatment of burn and scald is characterized in that the proportioning raw materials of described Chinese medicine composition composition powders is:
Astragalus membranaceus powder 3~15 weight portions
Rhizoma Cimicifugae powder 3~15 weight portions
Pseudobulbus Bletillae (Rhizoma Bletillae) powder 3~7 weight portions
Radix Et Rhizoma Rhei powder 3~15 weight portions
Hot pepper powder 3~9 weight portions
Corium elephatis powder 0.5~2 weight portion
Margarita powder 1~5 weight portion
Mentholum 1~5 weight portion
Moschus 0.08~0.15 weight portion
Indigo Naturalis 1~5 weight portion
2, a kind of Chinese medicine composition composition powders for the treatment of burn and scald as claimed in claim 1 is characterized in that the proportioning of described Chinese medicine composition is:
Astragalus membranaceus powder 9 weight portions
Rhizoma Cimicifugae powder 9 weight portions
Pseudobulbus Bletillae (Rhizoma Bletillae) powder 5 weight portions
Radix Et Rhizoma Rhei powder 9 weight portions
Hot pepper powder 5 weight portions
Corium elephatis powder 1 weight portion
Margarita powder 3 weight portions
Mentholum 3 weight portions
Moschus 0.1 weight portion
Indigo Naturalis 3 weight portions
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011078340A CN1164287C (en) | 2001-02-27 | 2001-02-27 | Composite Chinese medicine powder for treating burns and scalds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011078340A CN1164287C (en) | 2001-02-27 | 2001-02-27 | Composite Chinese medicine powder for treating burns and scalds |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1370569A true CN1370569A (en) | 2002-09-25 |
CN1164287C CN1164287C (en) | 2004-09-01 |
Family
ID=4656739
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB011078340A Expired - Fee Related CN1164287C (en) | 2001-02-27 | 2001-02-27 | Composite Chinese medicine powder for treating burns and scalds |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1164287C (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101919885B (en) * | 2009-06-16 | 2011-09-14 | 刘建伟 | Ointment for treating burns and scalds and preparation method thereof |
CN102283887A (en) * | 2011-09-07 | 2011-12-21 | 王全英 | Ointment for treating burn |
CN102688383A (en) * | 2011-12-21 | 2012-09-26 | 河南科技大学 | Traditional Chinese medicine composite for treating body surface ulcer or fester |
-
2001
- 2001-02-27 CN CNB011078340A patent/CN1164287C/en not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101919885B (en) * | 2009-06-16 | 2011-09-14 | 刘建伟 | Ointment for treating burns and scalds and preparation method thereof |
CN102283887A (en) * | 2011-09-07 | 2011-12-21 | 王全英 | Ointment for treating burn |
CN102688383A (en) * | 2011-12-21 | 2012-09-26 | 河南科技大学 | Traditional Chinese medicine composite for treating body surface ulcer or fester |
CN102688383B (en) * | 2011-12-21 | 2013-12-04 | 河南科技大学 | Traditional Chinese medicine composite for treating body surface ulcer or fester |
Also Published As
Publication number | Publication date |
---|---|
CN1164287C (en) | 2004-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1839941A (en) | Chinese prepared medicine for treating bone pain | |
CN100434109C (en) | Medicine ointment for treating burns and scalds and its prepn | |
CN101045133A (en) | External use medicine for treating burns or scald or skin lesion, and its preparing method | |
CN101143171B (en) | Traditional Chinese medicine and its preparation method and its application | |
CN102178817B (en) | Chinese medicinal composition for treating multiple lipomas | |
CN1164287C (en) | Composite Chinese medicine powder for treating burns and scalds | |
CN110075258A (en) | A kind of diabetic foot ulcer externally applied drug | |
CN1772077A (en) | Medicine liquid for treating burns and scalds and its prepn | |
CN103893611A (en) | Drug for treating kidney stone and preparation method of drug | |
CN1415345A (en) | Drug for curing scald, hrut and inflammations as well as hemorrhoids | |
CN103877457B (en) | Chinese medicinal preparation for treating renal calculus and preparation method thereof | |
CN1177607C (en) | Pile-treating Chinese medicine | |
CN1857685A (en) | Medicine ointment for treating swelling and pain in waist and knees | |
CN1814091A (en) | External-use Chinese medicine preparation for treating angeitis and diabetes foot | |
CN104666799A (en) | Blood circulation activating and blood stasis removing medicinal liquor for soft tissue injury and preparation method of medicinal liqour | |
CN110478416A (en) | The composition and its preparation method and application for treating rheumatic rheumatoid arthritis | |
CN104491324A (en) | Aerosol for postoperative patient to promote blood circulation and remove obstruction in channels | |
CN1141105C (en) | Cancer curing medicine liquid | |
CN1275623C (en) | Green peach hull and psoralea fruit containing liquor for treating leucoderma and alphos | |
CN114452365B (en) | Traditional Chinese medicine preparation for treating chalazion | |
CN115192689B (en) | Traditional Chinese medicine composition for treating neck, shoulder, waist and leg pain, application and traditional Chinese medicine preparation thereof | |
CN1180819C (en) | Chinese medicine composition for treating prolapse of lumbar intervertebral disc and sciatica | |
CN105125653A (en) | Drug for treating myasthenia gravis and preparation method thereof | |
CN1531961A (en) | Chinese medine for treating paraplegia | |
CN104523978A (en) | Traditional Chinese medicine ointment for treating swelling and pain in anus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |